DekaBank Deutsche Girozentrale’s Agios Pharmaceuticals AGIO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$1.27M	–	1104
2025 Q4	$1.27M	Hold	40,000	–	–	﹤0.01%	834
2025 Q3	$1.56M	Hold	40,000	–	–	﹤0.01%	792
2025 Q2	$1.33M	Hold	40,000	–	–	﹤0.01%	811
2025 Q1	$1.19M	Hold	40,000	–	–	﹤0.01%	816
2024 Q4	$1.31M	Hold	40,000	–	–	﹤0.01%	821
2024 Q3	$1.8M	Hold	40,000	–	–	﹤0.01%	777
2024 Q2	$1.73M	Hold	40,000	–	–	﹤0.01%	786
2024 Q1	$1.15M	Hold	40,000	–	–	﹤0.01%	849
2023 Q4	$901K	Hold	40,000	–	–	﹤0.01%	921
2023 Q3	$982K	Hold	40,000	–	–	﹤0.01%	883
2023 Q2	$1.09M	Buy	40,000 +20,000	+100%	+$498K	﹤0.01%	856
2023 Q1	$443K	Hold	20,000	–	–	﹤0.01%	1033
2022 Q4	$542K	Hold	20,000	–	–	﹤0.01%	1017
2022 Q3	$568K	Hold	20,000	–	–	﹤0.01%	1012
2022 Q2	$439K	Buy	+20,000	New	+$452K	﹤0.01%	1042
2022 Q1	–	Sell	-2,800	Closed	-$94K	–	1326
2021 Q4	$94K	Sell	2,800 -33,900	-92%	-$1.36M	﹤0.01%	1354
2021 Q3	$1.69M	Hold	36,700	–	–	﹤0.01%	757
2021 Q2	$1.94M	Hold	36,700	–	–	0.01%	732
2021 Q1	$1.8M	Buy	36,700 +2,800	+8%	+$139K	0.01%	730
2020 Q4	$1.49M	Sell	33,900 -1,700	-5%	-$67.2K	0.01%	745
2020 Q3	$1.21M	Buy	+35,600	New	+$1.56M	0.01%	709
2020 Q1	–	Sell	-2,982	Closed	-$143K	–	1056
2019 Q4	$143K	Buy	+2,982	New	+$113K	﹤0.01%	995

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AGIO Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 40,000 shares — an estimated $1.27M sold.

DekaBank Deutsche Girozentrale first reported a position in AGIO in Q4 2019 and held it in 22 quarters. The position peaked at $1.94M in Q2 2021. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 40,000 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.27M.
DekaBank Deutsche Girozentrale first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 22 quarters.
DekaBank Deutsche Girozentrale's Agios Pharmaceuticals position peaked at $1.94M in Q2 2021.
234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.